New Mexico 2025 Regular Session Status: Passed Senate 3 D cosponsors

SB 119 — INVESTMENT IN BIOSCIENCE COMPANIES

Last action — action postponed indefinitely

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2025 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

429 added · 361 removed

Plain-language change summary

The latest version of Senate Bill 119 includes some clarifications regarding the legislative process, explicitly stating that the document may show proposed or adopted amendments. Additionally, it emphasizes that this bill is intended to support the investment in bioscience companies by establishing clear requirements and penalties. These changes are important because they aim to streamline the understanding of the legislative process and reinforce commitments to economic development in the bioscience sector in New Mexico.

→
Previous
Latest
SENATE FINANCE COMMITTEE SUBSTITUTE FOR SENATE BILL 119 57TH LEGISLATURE -STATEOFNEWMEXICO- FIRST SESSION, 2025 4 6 8 10 AN ACT RELATING TO ECONOMIC DEVELOPMENT;
SENATE FINANCE COMMITTEE SUBSTITUTE FOR SENATE BILL 119 57TH LEGISLATURE - STATE OF NEW MEXICO - FIRST SESSION, 2025 This document may incorporate amendments proposed by a committee, but not yet adopted, as well as amendments that have been adopted during the current legislative session.
AMENDING AND ENACTING SECTIONS OF THE BIOSCIENCE DEVELOPMENT ACT;
The document is a tool to show amendments in context and cannot be used for the purpose of adding amendments to legislation.
AUTHORIZING INVESTMENT IN BIOSCIENCE COMPANIES;
h AN ACT g o RELATING TO ECONOMIC DEVELOPMENT;
AMENDING AND ENACTING t hr g e i k SECTIONS OF THE BIOSCIENCE DEVELOPMENT ACT;
AUTHORIZING h r i s INVESTMENT IN BIOSCIENCE COMPANIES;
PROVIDING PENALTIES.
h , t, PROVIDING PENALTIES.
16 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
e u g e b l e e h n d d i = = o h BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
e t 17 SECTION 1.
l ] b ,d i a º e SECTION 1.
Section 9-15E-1 NMSA 1978 (being Laws 2017, w l n d 18 Chapter 134, Section 1) is amended to read:
Section 9-15E-1 NMSA 1978 (being Laws 2017, r i = r t e w d m a n o Chapter 134, Section 1) is amended to read:
= = 19 a l "9-15E-1.
d m :
SHORT TITLE.--[This act] Chapter 9, Article 15E i a e r 20 NMSA 1978 may be cited as the "Bioscience Development Act"." a t m m 21 SECTION 2.
b e d s º o t n = .231471.2AIC March 6, 2025 (11:50am) s k m e e a n e d r e l u [ A d SFC/SB 119 "9-15E-1.
Section 9-15E-2 NMSA 1978 (being Laws 2017, d r e 22 Chapter 134, Section 2) is amended to read:
SHORT TITLE.--[This act ] Chapter 9, Article 15E NMSA 1978 may be cited as the "Bioscience Development Act"." SECTION 2.
c e s k 23 "9-15E-2.
Section 9-15E-2 NMSA 1978 (being Laws 2017, Chapter 134, Section 2) is amended to read:
DEFINITIONS.--As used in the Bioscience e a n b 24 Development Act:
"9-15E-2.
u [ A.
DEFINITIONS.--As used in the Bioscience Development Act:
"authority" means the New Mexico bioscience .231471.2 SFC/SB 119 authority;
A.
"authority" means the New Mexico bioscience authority;
and (5) agriculture and chemicals related to bioscience;
and h (5) agriculture and chemicals related to g o bioscience;
C.
t hr g e i k C.
"board of directors" means the board of directors of the authority;
"board of directors" means the board of h r i s directors of the authority;
D.
h , t, Sfl1º D.
"financial assistance" means tax incentives, grants, loans and other financial benefits provided for projects to a qualified entity on terms and conditions approved e t 17 by the authority;
"co-investing organization" means a person e u g e b l e e h principally engaged in holding, managing and investing n d d i = = o h securities, including a venture capital firm, a growth equity l ] b ,d i a º e firm, a private equity firm and an angel investment firm;»Sfl1 r i = r t e w d m a n o Sfl1º D.»Sfl1 Sfl1ºE.»Sfl1 "financial assistance" d m :
w l n d 18 E.
b e d s º o t n = .231471.2AIC March 6, 2025 (11:50am) s k m e - 2 - e a n e d r e l u [ A d SFC/SB 119 means tax incentives, grants, loans and other financial benefits provided for projects to a qualified entity on terms and conditions approved by the authority;
"national laboratories" means Los Alamos = = 19 national laboratory and Sandia national laboratories;
Sfl1º F.
[and] a l i a e r 20 F.
"immediate family" means those persons related by blood or marriage as well as stepchildren, foster children and adopted children or persons who live in the same residence and maintain a single economic unit;»Sfl1 Sfl1º E.»Sfl1 Sfl1ºG.»Sfl1 "national laboratories" means Los Alamos national laboratory and Sandia national laboratories;
"New Mexico business" means, in the case of a a t m m 21 corporation or limited liability company, a business with the d r e 22 business's principal office and a majority of the business's c e s k 23 full-time employees located in New Mexico or, in the case of a e a n b 24 limited partnership, a business with the business's principal u [ place of business and at least eighty percent of the business's .231471.2 - 2 - SFC/SB 119 assets located in New Mexico;
[and ] Sfl1ºF.»Sfl1 Sfl1ºH.»Sfl1 "New Mexico business" means, in the case of a corporation or limited liability company, a business with the business's principal office and a majority of the business's full-time employees located in New Mexico or, in the case of a limited partnership, a business with the business's principal place of business and at least eighty percent of the business's assets located in New Mexico;
G.
Sfl1ºG.»Sfl1 Sfl1ºI.»Sfl1 "portfolio business" h means a bioscience business in which the authority has made an g o t hr investment;
"portfolio business" means a bioscience business in which the authority has made an investment;
and g e i k [F.] Sfl1ºH.»Sfl1 Sfl1ºJ.»Sfl1 "research h r i s institutions" means the university of New Mexico, New Mexico h , t, e u g state university and the New Mexico institute of mining and e b l e e h technology." n d d i = = o h SECTION 3.
and [F.] H.
Section 9-15E-7 NMSA 1978 (being Laws 2017, l ] b ,d i a º e r i = r Chapter 134, Section 7) is amended to read:
"research institutions" means the university of New Mexico, New Mexico state university and the New Mexico institute of mining and technology." SECTION 3.
t e w d m a n o "9-15E-7.
Section 9-15E-7 NMSA 1978 (being Laws 2017, Chapter 134, Section 7) is amended to read:
FUND CREATED.-- d m :
"9-15E-7.
b e d s º o t n = .231471.2AIC March 6, 2025 (11:50am) s k m e - 3 - e a n e d r e l u [ A d SFC/SB 119 SFC/SB 119 A.
FUND CREATED.-- A.
Any general fund balance from money appropriated by the legislature in the fund shall not e t 17 revert at the end of a fiscal year.
Any general fund balance from money appropriated by the legislature in the fund shall not revert at the end of a fiscal year.
w l n d 18 B.
B.
Except as provided in this section, money = = 19 received by the authority shall be deposited in the fund, a l i a e r 20 including:
Except as provided in this section, money received by the authority shall be deposited in the fund, including:
a t m m 21 (1) money appropriated by the legislature;
(1) money appropriated by the legislature;
d r e 22 (2) interest earned upon money in the fund;
(2) interest earned upon money in the fund;
c e s k 23 (3) property or securities acquired through e a n b 24 the use of money belonging to the fund;
(3) property or securities acquired through the use of money belonging to the fund;
u [ (4) all earnings of property or securities .231471.2 - 3 - SFC/SB 119 acquired pursuant to Paragraph (3) of this subsection;
(4) all earnings of property or securities h acquired pursuant to Paragraph (3) of this subsection;
Show all 96 changed rows (56 more)
Previous
Latest
(5) all earnings on investments made by the authority;
g o (5) all earnings on investments made by the t hr g e i k authority;
[(5)] (6) all of the money received by the authority from a public or private source;
h r i s [(5)] (6) all of the money received by the h , t, authority from a public or private source;
and [(6)] (7) fees, rents or other charges imposed and collected by the authority.
and e u g e b l e e h [(6)] (7) fees, rents or other charges imposed n d d i = = o h and collected by the authority.
C.
l ] b ,d i a º e C.
Disbursements from the bioscience development fund shall be made only upon warrant drawn by the secretary of finance and administration pursuant to vouchers signed by the secretary of economic development or the secretary's designee pursuant to the Bioscience Development Act." SECTION 4.
Disbursements from the bioscience development r i = r t e w d fund shall be made only upon warrant drawn by the secretary of m a n o d m :
b e d s º o t n = .231471.2AIC March 6, 2025 (11:50am) s k m e - 4 - e a n e d r e l u [ A d SFC/SB 119 finance and administration pursuant to vouchers signed by the secretary of economic development or the secretary's designee pursuant to the Bioscience Development Act." SECTION 4.
REPORT TO THE GOVERNOR AND THE LEGISLATURE.-- The authority shall submit a report of its activities for the e t 17 prior fiscal year to the governor and to the appropriate w l n d 18 interim committees of the legislature not later than October 1 = = 19 of each year, and the report shall be posted on the authority's a l i a e r 20 website." a t m m 21 SECTION 5.
REPORT TO THE GOVERNOR AND THE LEGISLATURE.-- The authority shall submit a report of its activities for the prior fiscal year to the governor and to the appropriate interim committees of the legislature not later than October 1 of each year, and the report shall be posted on the authority's website." SECTION 5.
A new section of the Bioscience Development d r e 22 Act is enacted to read:
A new section of the Bioscience Development Act is enacted to read:
c e s k 23 "[NEW MATERIAL] INVESTMENTS--REQUIREMENTS--REIMBURSEMENT e a n b 24 OBLIGATIONS.-- u [ A.
"[NEW MATERIAL] INVESTMENTS--REQUIREMENTS--REIMBURSEMENT OBLIGATIONS.-- A.
The authority may invest in a bioscience .231471.2 - 4 - SFC/SB 119 business that:
The authority may invest in a bioscience business that:
(1) is a New Mexico business that shall maintain a minimum in-state workforce of five employees with a minimum median annual salary of sixty thousand dollars ($60,000) as a condition of the investment;
(1) is a New Mexico business that shall h maintain a minimum in-state workforce of five employees with a g o t hr minimum median annual salary of sixty thousand dollars g e i k ($60,000) as a condition of the investment;
or (2) pursuant to a contract with the authority, shall relocate to New Mexico and agree to maintain the bioscience business as a New Mexico business for a minimum period of five years as a condition of the investment and maintain a minimum in-state workforce of five employees with a minimum median annual salary of sixty thousand dollars ($60,000).
or h r i s (2) pursuant to a contract with the authority, h , t, shall relocate to New Mexico and agree to maintain the e u g e b l e e h bioscience business as a New Mexico business for a minimum n d d i = = o h period of five years as a condition of the investment and l ] b ,d i a º e maintain a minimum in-state workforce of five employees with a r i = r t e w d m a n o minimum median annual salary of sixty thousand dollars d m :
b e d s º o t n = .231471.2AIC March 6, 2025 (11:50am) s k m e - 5 - e a n e d r e l u [ A d SFC/SB 119 SFC/SB 119 ($60,000).
e t 17 (1) the market opportunity presented by the w l n d 18 product or service offered by the business;
(1) the market opportunity presented by the product or service offered by the business;
= = 19 (2) the current financial stability and status a l i a e r 20 of the business;
(2) the current financial stability and status of the business;
a t m m 21 (3) the expertise and experience in bioscience d r e 22 and business start-ups of the officers of the business;
(3) the expertise and experience in bioscience and business start-ups of the officers of the business;
c e s k 23 (4) the business's business plan and strategy e a n b 24 to capture or create a market for the business's products or u [ services;
(4) the business's business plan and strategy to capture or create a market for the business's products or services;
.231471.2 - 5 - SFC/SB 119 (5) the business's competitive assets, including intellectual and physical properties;
(5) the business's competitive assets, including intellectual and physical properties;
(6) the established business's exit strategy;
h (6) the established business's exit strategy;
(7) the projected economic benefits of the New Mexico business over the next five years, including projected sales, revenue and the number of in-state employees;
g o (7) the projected economic benefits of the New t hr g e i k Mexico business over the next five years, including projected h r i s sales, revenue and the number of in-state employees;
and (8) the projected social benefits of the business in accordance with procurement preferences provided in state or federal law.
and h , t, (8) the projected social benefits of the e u g e b l e e h business in accordance with procurement preferences provided in n d d i = = o h state or federal law.
C.
l ] b ,d i a º e C.
Investments made pursuant to this section shall be made with a co-investing organization chosen by the authority in consultation with the university of New Mexico purchasing office through a competitive process;
Investments made pursuant to this section shall r i = r t e w d be made with a co-investing organization chosen by the m a n o d m :
b e d s º o t n = .231471.2AIC March 6, 2025 (11:50am) s k m e - 6 - e a n e d r e l u [ A d SFC/SB 119 authority in consultation with the university of New Mexico purchasing office through a competitive process;
(1) the officer of the co-investing organization with final decision-making authority for a co- e t 17 investment with the authority shall have a minimum of five w l n d 18 years of experience investing in bioscience companies or a = = 19 minimum of ten years of experience investing in start-up a l i a e r 20 companies;
(1) the officer of the co-investing organization with final decision-making authority for a co- investment with the authority shall have a minimum of five years of experience investing in bioscience companies or a minimum of ten years of experience investing in start-up companies;
and a t m m 21 (2) the authority's investment in a bioscience d r e 22 business shall be no more than one-third of the combined c e s k 23 investment of the authority and a co-investor organization in e a n b 24 that business within a twelve-month period, making the u [ co-investor organization the lead investor and the authority a .231471.2 - 6 - SFC/SB 119 follow-on investor.
and (2) the authority's investment in a bioscience business shall be no more than one-third of the combined investment of the authority and a co-investor organization in that business within a twelve-month period, making the co-investor organization the lead investor and the authority a follow-on investor.
(1) if the portfolio business fails to meet its contractual obligations pursuant to this section, it shall either:
(1) if the portfolio business fails to meet h its contractual obligations pursuant to this section, it shall g o either:
(a) fully reimburse the authority for the bioscience development fund's cost basis in the portfolio business;
t hr g e i k (a) fully reimburse the authority for h r i s the bioscience development fund's cost basis in the portfolio h , t, business;
or (b) document to the satisfaction of the authority that the portfolio business has provided economic benefits to the state that exceed the authority's cost basis in the business;
or e u g e b l e e h (b) document to the satisfaction of the n d d i = = o h authority that the portfolio business has provided economic l ] b ,d i a º e benefits to the state that exceed the authority's cost basis in r i = r t e w d m a n o the business;
(2) in any sale of a majority of the assets or a majority of the voting stock of the business to a single entity or set of affiliated entities, the acquiring entity or e t 17 set of affiliated entities shall assume the legal obligations w l n d 18 of the contract with the authority;
d m :
= = 19 (3) in a bankruptcy proceeding, liquidation or a l i a e r 20 deemed liquidation event for the portfolio business, a claim by a t m m 21 the authority shall be paid first, except as otherwise provided d r e 22 by federal or state law;
b e d s º o t n = .231471.2AIC March 6, 2025 (11:50am) s k m e - 7 - e a n e d r e l u [ A d SFC/SB 119 SFC/SB 119 (2) in any sale of a majority of the assets or a majority of the voting stock of the business to a single entity or set of affiliated entities, the acquiring entity or set of affiliated entities shall assume the legal obligations of the contract with the authority;
and c e s k 23 (4) milestones shall be met quarterly, semi- e a n b 24 annually or annually on a case-by-case basis dependent on the u [ type of investment to release a disbursement of funds;
(3) in a bankruptcy proceeding, liquidation or deemed liquidation event for the portfolio business, a claim by the authority shall be paid first, except as otherwise provided by federal or state law;
provided .231471.2 - 7 - SFC/SB 119 that milestones may include:
and (4) milestones shall be met quarterly, semi- annually or annually on a case-by-case basis dependent on the type of investment to release a disbursement of funds;
provided that milestones may include:
(c) signing partnership or collaboration agreements;
h (c) signing partnership or collaboration g o agreements;
(d) being awarded grants and contracts with agencies, foundations or private industry;
t hr g e i k (d) being awarded grants and contracts h r i s with agencies, foundations or private industry;
(e) filing new intellectual property patents and receiving granted patents;
h , t, (e) filing new intellectual property e u g e b l e e h patents and receiving granted patents;
(f) sales and sales agreements for equipment, goods and services;
n d d i = = o h (f) sales and sales agreements for l ] b ,d i a º e equipment, goods and services;
(g) investigational new drug approval;
r i = r t e w d (g) investigational new drug approval;
(h) in vitro or in vivo proof of technology;
m a n o d m :
(i) immunogenicity data to support e t 17 investigational new drug filing;
b e d s º o t n = .231471.2AIC March 6, 2025 (11:50am) s k m e - 8 - e a n e d r e l u [ A d SFC/SB 119 (h) in vitro or in vivo proof of technology;
and w l n d 18 (j) other milestones deemed appropriate = = 19 for the investment by the authority.
(i) immunogenicity data to support investigational new drug filing;
a l i a e r 20 E.
and (j) other milestones deemed appropriate for the investment by the authority.
When a portfolio business must compensate the a t m m 21 authority pursuant to this section due to an acquisition by d r e 22 another entity or a relocation outside of the state, the c e s k 23 authority, in collaboration with local investors, may accept e a n b 24 stock in the acquiring entity or in the relocated business in u [ lieu of a cash payment if the value of the stock would be equal .231471.2 - 8 - SFC/SB 119 to or greater than the amount that the business must compensate." SECTION 6.
E.
When a portfolio business must compensate the authority pursuant to this section due to an acquisition by another entity or a relocation outside of the state, the authority, in collaboration with local investors, may accept stock in the acquiring entity or in the relocated business in lieu of a cash payment if the value of the stock would be equal to or greater than the amount that the business must compensate." SECTION 6.
An entity that has benefited from a contractual or other activity with the authority, including the receipt of co-investment funding, shall:
An entity that has benefited from a contractual h or other activity with the authority, including the receipt of g o t hr co-investment funding, shall:
(1) have no employee related to a member of the board of directors;
g e i k (1) have no employee related to a member of h r i s the board of directors Sfl1º or a member of a director's h , t, immediate family»Sfl1 ;
and (2) not hire a member of the board of directors nor an employee of the authority within one year of the completion of the board member's term of office or the employee's service with the authority.
and e u g e b l e e h (2) not hire a member of the board of n d d i = = o h directors Sfl1ºnor»Sfl1 Sfl1º,»Sfl1 an employee of the l ] b ,d i a º e authority Sfl1º nor a member of a director's or an employee's r i = r t e w d m a n o immediate family»Sfl1 within one year of the completion of the d m :
b e d s º o t n = .231471.2AIC March 6, 2025 (11:50am) s k m e - 9 - e a n e d r e l u [ A d SFC/SB 119 SFC/SB 119 board member's term of office or the employee's service with the authority.
Any person who knowingly and willfully violates the provisions of Subsection A of this section is guilty of a e t 17 misdemeanor and shall be sentenced pursuant to the provisions w l n d 18 of Subsection B of Section 30-1-6 NMSA 1978.
Any person who knowingly and willfully violates the provisions of Subsection A of this section is guilty of a misdemeanor and shall be sentenced pursuant to the provisions of Subsection B of Section 30-1-6 NMSA 1978.
An alleged = = 19 violation of Subsection A of this section may be reported to a l i a e r 20 the attorney general or district attorney for enforcement." a t m m 21 SECTION 7.
An alleged violation of Subsection A of this section may be reported to the attorney general or district attorney for enforcement." SECTION 7.
A new section of the Bioscience Development d r e 22 Act is enacted to read:
A new section of the Bioscience Development Act is enacted to read:
c e s k 23 "[NEW MATERIAL] INVESTMENT REPORTING.--Quarterly reports e a n b 24 for all investments shall be presented to the board of u [ directors by the board of the investment committee during .231471.2 - 9 - SFC/SB 119 regular board meetings, and such reports shall be publicly available pursuant to the Open Meetings Act." SECTION 8.
"[NEW MATERIAL ] INVESTMENT REPORTING.--Quarterly reports for all investments shall be presented to the board of directors by the board of the investment committee during regular board meetings, and such reports shall be publicly available pursuant to the Open Meetings Act." SECTION 8.
EFFECTIVE DATE.--The effective date of the provisions of this act is July 1, 2025.
EFFECTIVE DATE.--The effective date of the h provisions of this act is July 1, 2025.
- 10 - 7 9 11 13 15 e t 17 w l n d 18 = = 19 a l i a e r 20 a t m m 21 d r e 22 c e s k 23 e a n b 24 u [ .231471.2
u » r - 10 - t h g e l i h r i s h , e h t u g e b l e e , gh n d d i = = o h l ] b ,d i a º r e r = t e w d m a n o d m :
b r e t º o t n = .231471.2AIC March 6, 2025 (11:50am) s k m e e a n e d r e l u [ A d
View plain text versions (3)

Action History

  1. action postponed indefinitely

  2. DO PASS committee report adopted

  3. Sent to House Commerce & Economic Development Committee & House Judiciary Committee

  4. passed Senate

  5. floor substitute adopted (1 amendment)

  6. DO NOT PASS, replaced with committee substitute

  7. WITHOUT RECOMMENDATION, as amended, committee report adopted

  8. Sent to Senate Judiciary Committee & Senate Finance Committee

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

3 sponsors · 0 co-sponsors · 109 not signed on · 13 voted No

Sponsors (3)

Co-sponsors (0)

None.

Not signed on (109)

109 members have not signed on to this bill.

Show all 109 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

senate passage

Passed 26 Yea · 15 Nay · 1 Other
Party YeaNayPresentNot Voting
Democrat 22300
Republican 41001
Unaffiliated 0200
Total 261501
% of votes cast 62%36%0%2%
How each member voted (42)
Member Party Vote
PAUL — Nay
SEDILLO-LOPEZ — Nay
Angel M. Charley Democrat Yea
Antoinette Sedillo Lopez Democrat Yea
Antonio Maestas Democrat Yea
Benny Shendo, Jr. Democrat Yea
Carrie Hamblen Democrat Yea
Cindy Nava Democrat Yea
Elizabeth "Liz" Stefanics Democrat Yea
George K. Muñoz Democrat Yea
Harold Pope Democrat Yea
Heather Berghmans Democrat Yea
Jeff Steinborn Democrat Yea
Joseph Cervantes Democrat Nay
Katy Duhigg Democrat Nay
Leo Jaramillo Democrat Yea
Linda M. Trujillo Democrat Yea
Martin Hickey Democrat Yea
Micaelita Debbie O'Malley Democrat Yea
Michael Padilla Democrat Yea
Mimi Stewart Democrat Yea
Natalie Figueroa Democrat Yea
Pete Campos Democrat Yea
Peter Wirth Democrat Yea
Roberto "Bobby" J. Gonzales Democrat Yea
Shannon D. Pinto Democrat Nay
William P. Soules Democrat Yea
Anthony L. Thornton Republican Nay
Candy Spence Ezzell Republican Nay
Craig W. Brandt Republican Not Voting
Crystal Brantley Republican Nay
David M. Gallegos Republican Nay
Gabriel Ramos Republican Nay
James G. Townsend Republican Yea
Jay C. Block Republican Yea
Joshua A. Sanchez Republican Nay
Larry R. Scott Republican Nay
Nicole Tobiassen Republican Yea
Pat Boone Republican Nay
Pat Woods Republican Nay
Steve D. Lanier Republican Nay
William E. Sharer Republican Yea

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 119?
SB 119 is sponsored by Meredith A. Dixon (Democrat), Martin Hickey (Democrat), and George K. Muñoz (Democrat).
What is the current status of SB 119?
This bill died with 2025 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 119?
Track SB 119 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 119

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 119

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →